Takahiro Wakasaki
7PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 28, 2022
Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study.Takahiro Wakasaki, Tomomi Manako, Ryuji Yasumatsu
|Aug 23, 2020
Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.Takahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda
|Aug 19, 2020
Clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse events.Ryuji Yasumatsu, Mioko Matsuo, Takahiro Wakasaki
|May 14, 2020
A clinical analysis of sinonasal squamous cell carcinoma: a comparison of de novo squamous cell carcinoma and squamous cell carcinoma arising from inverted papilloma.Ryuji Yasumatsu, Rina Jiromaru, Takahiro Hongo
|Jun 05, 2019
Small Cell Carcinoma in the Head and Neck.Takahiro Wakasaki, Ryuji Yasumatsu, Muneyuki Masuda
|Aug 18, 2017
Musashi-1 is the candidate of the regulator of hair cell progenitors during inner ear regeneration.Takahiro Wakasaki, Hiroaki Niiro, Siamak Jabbarzadeh-Tabrizi
Pageof 2
